X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (350) 350
gastroenterology & hepatology (306) 306
female (226) 226
male (209) 209
middle aged (195) 195
adult (177) 177
index medicus (168) 168
aged (118) 118
ursodeoxycholic acid - therapeutic use (90) 90
ursodeoxycholic acid (85) 85
risk factors (76) 76
liver cirrhosis, biliary - drug therapy (73) 73
primary sclerosing cholangitis (69) 69
natural-history (67) 67
primary biliary-cirrhosis (64) 64
cholagogues and choleretics - therapeutic use (60) 60
prognosis (59) 59
liver transplantation (56) 56
treatment outcome (49) 49
liver - pathology (47) 47
diagnosis (45) 45
disease (45) 45
retrospective studies (44) 44
liver cirrhosis, biliary - complications (43) 43
therapy (43) 43
ulcerative-colitis (42) 42
cholangitis, sclerosing - drug therapy (39) 39
double-blind (39) 39
gastroenterology and hepatology (39) 39
survival (38) 38
disease progression (37) 37
primary biliary cirrhosis (37) 37
risk (37) 37
cholangitis, sclerosing - complications (36) 36
follow-up studies (36) 36
liver (35) 35
ursodiol (35) 35
liver diseases (33) 33
article (32) 32
medicine, general & internal (32) 32
liver-transplantation (31) 31
alkaline phosphatase - blood (30) 30
biopsy (30) 30
dose ursodeoxycholic acid (30) 30
oncology (30) 30
research (30) 30
bilirubin - blood (29) 29
care and treatment (29) 29
cirrhosis (29) 29
pharmacology & pharmacy (29) 29
prevalence (29) 29
time factors (29) 29
cholangitis (28) 28
model (28) 28
adolescent (27) 27
biochemical response (27) 27
gastroenterology (27) 27
liver cirrhosis, biliary - blood (27) 27
cancer (26) 26
placebo-controlled trial (26) 26
survival analysis (26) 26
cholangitis, sclerosing - pathology (25) 25
pilot projects (25) 25
risk-factors (25) 25
biliary cirrhosis (24) 24
cholangitis, sclerosing - diagnosis (24) 24
liver cirrhosis, biliary - pathology (24) 24
medicine & public health (24) 24
cholangitis, sclerosing - therapy (23) 23
features (23) 23
inflammatory-bowel-disease (23) 23
prospective studies (23) 23
abridged index medicus (22) 22
cholangiocarcinoma (22) 22
digestive system diseases (22) 22
double-blind method (22) 22
liver cirrhosis, biliary - diagnosis (22) 22
multicenter (22) 22
young adult (22) 22
cholestasis (21) 21
controlled trial (21) 21
epidemiology (21) 21
mutation (21) 21
aged, 80 and over (20) 20
hepatology (20) 20
liver cirrhosis, biliary - immunology (20) 20
aspartate aminotransferases - blood (19) 19
colorectal cancer (19) 19
drug therapy, combination (19) 19
health aspects (19) 19
liver cirrhosis, biliary - mortality (19) 19
medical research (19) 19
bile (18) 18
cholangitis, sclerosing - blood (18) 18
predictive value of tests (18) 18
transplantation (18) 18
ursodeoxycholic acid - administration & dosage (18) 18
cholangiography (17) 17
cohort studies (17) 17
immunosuppressive agents - therapeutic use (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Gastroenterology, ISSN 0002-9270, 09/2011, Volume 106, Issue 9, pp. 1638 - 1645
Journal Article
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, ISSN 0815-9319, 02/2002, Volume 17, pp. S186 - S190
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease that affects a high proportion of the world's population. Insulin resistance and oxidative... 
MITOCHONDRIAL ABNORMALITIES | OBESE PATIENTS | WEIGHT-REDUCTION | INSULIN-RESISTANCE | OVERWEIGHT PATIENTS | NONALCOHOLIC STEATOHEPATITIS | ALANINE AMINOTRANSFERASE | ASYMPTOMATIC PATIENTS | NATURAL-HISTORY | GASTROENTEROLOGY & HEPATOLOGY | CRYPTOGENIC CIRRHOSIS
Journal Article
Gastroenterology, ISSN 0016-5085, 2013, Volume 145, Issue 3, pp. 521 - 536
Primary sclerosing cholangitis (PSC), first described in the mid-1850s, is a complex liver disease that is heterogeneous in its presentation. PSC is... 
Gastroenterology and Hepatology | Autoimmune Disease | Inflammatory Bowel Disease | Cholestatic Liver Disease | Cholangiocarcinoma | DOSE URSODEOXYCHOLIC ACID | LIVER-TRANSPLANTATION | RISK-FACTORS | WIDE ASSOCIATION ANALYSIS | ULCERATIVE-COLITIS | NATURAL-HISTORY | INFLAMMATORY-BOWEL-DISEASE | IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS | COLORECTAL NEOPLASIA | GASTROENTEROLOGY & HEPATOLOGY | BILIARY EPITHELIAL-CELLS | Liver Transplantation | Immunosuppressive Agents | Cholangiocarcinoma - diagnosis | Humans | Colonic Neoplasms - diagnosis | Cholangiocarcinoma - etiology | Cholagogues and Choleretics - therapeutic use | Ursodeoxycholic Acid - therapeutic use | Bile Ducts, Intrahepatic | Gallbladder Neoplasms - etiology | Colonic Neoplasms - etiology | Colonic Neoplasms - therapy | Gallbladder Neoplasms - diagnosis | Gallbladder Neoplasms - therapy | Cholangiocarcinoma - therapy | Diagnosis, Differential | Genetic Predisposition to Disease | Cholangiopancreatography, Endoscopic Retrograde | Combined Modality Therapy | Cholangitis, Sclerosing - etiology | Immunity, Innate | Bile Duct Neoplasms - etiology | Bile Duct Neoplasms - diagnosis | Bile Duct Neoplasms - therapy | Cholangitis, Sclerosing - therapy | Intestines - microbiology | Cholangitis, Sclerosing - diagnosis | Metagenome | Development and progression | Care and treatment | Diagnosis | Liver cirrhosis | cholestatic liver disease | cholangiocarcinoma | autoimmune disease | inflammatory bowel disease
Journal Article